Scarica l'app Stockscreener
1.87
0.53%
-0.010
Dopo l'orario di chiusura:
1.86
-0.01
-0.53%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.88
Aprire:
$1.87
Volume 24 ore:
263.29K
Relative Volume:
1.11
Capitalizzazione di mercato:
$83.01M
Reddito:
-
Utile/perdita netta:
$-28.54M
Rapporto P/E:
-2.9219
EPS:
-0.64
Flusso di cassa netto:
$-22.72M
1 W Prestazione:
+0.54%
1M Prestazione:
+8.09%
6M Prestazione:
+7.47%
1 anno Prestazione:
-63.62%
Intervallo 1D:
$1.87
$1.88
Intervallo di 1 settimana:
$1.86
$1.88
Portata 52W:
$1.40
$7.88
Essa Pharma Inc Stock (EPIX) Company Profile
Nome
Essa Pharma Inc
Settore
Industria
Telefono
(778) 331-0962
Indirizzo
SUITE 720, VANCOUVER, BC
Confronta EPIX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EPIX
Essa Pharma Inc
|
1.87 | 82.47M | 0 | -28.54M | -22.72M | -0.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.49 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
545.53 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.52 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
566.14 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.93 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
Essa Pharma Inc Stock (EPIX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-04 | Downgrade | Jefferies | Buy → Hold |
| 2024-11-04 | Downgrade | Oppenheimer | Outperform → Perform |
| 2024-11-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-06-26 | Ripresa | Oppenheimer | Outperform |
| 2021-03-04 | Iniziato | Piper Sandler | Overweight |
| 2021-01-11 | Reiterato | H.C. Wainwright | Buy |
| 2020-11-02 | Iniziato | Jefferies | Buy |
| 2019-10-25 | Iniziato | Oppenheimer | Outperform |
Mostra tutto
Essa Pharma Inc Borsa (EPIX) Ultime notizie
Is ESSA Pharma Inc. a good long term investmentAccelerated financial growth - Autocar Professional
What drives ESSA Pharma Inc. stock priceHigh-impact stock picks - jammulinksnews.com
ESSA Pharma Inc. Stock Analysis and ForecastRecord-setting profit potential - Autocar Professional
What analysts say about ESSA Pharma Inc. stockUnstoppable investment returns - Autocar Professional
ESSA Pharma to Be Acquired by XenoTherapeutics - Global Legal Chronicle
How ESSA Pharma Inc. stock performs during market volatilityFree Stock Market Trend Analysis - Newser
What makes ESSA Pharma Inc. stock price move sharplyBreakout Momentum Stocks - Newser
XenoTherapeutics to acquire ESSA Pharma in deal backed by XOMA Royalty - Canadian Lawyer Magazine
Why ESSA Pharma Inc. stock attracts strong analyst attentionWeekly Double Return List - Newser
ESSA Pharma to be acquired by XenoTherapeutics in all-cash deal - Investing.com Australia
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of ESSA Pharma Inc. (NASDAQ: EPIX) - TradingView
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of ESSA Pharma Inc. (NASDAQ: EPIX) - GlobeNewswire Inc.
EPIX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of ESSA Pharma Inc. is Fair to Shareholders - Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Monogram Technologies Inc. (NasdaqMGRM), Veritex Holdings, Inc. (NasdaqVBTX), ESSA Pharma Inc. (NasdaqEPIX), Waters Corporation (NYSEWAT - Morningstar
ESSA Pharma Enters into a Business Combination Agreement with XenoTherapeutics - MarketScreener
EPIX SEC FilingsEssa Pharma 10-K, 10-Q, 8-K Forms - Stock Titan
ESSA Pharma to be Acquired by XenoTherapeutics, Backed by XOMA Royalty - citybiz
ESSA Pharma to be Acquired by XenoTherapeutics - TipRanks
ESSA Pharma Inc. Announces Definitive Agreement to be Acquired b - GuruFocus
Essa Pharma Inc. announces definitive agreement to be acquired by Xenotherapeutics, Inc., backed by XOMA Royalty Corporation in all-cash transaction - MarketScreener
ESSA Pharma Inc. Announces Definitive Agreement to be Acquired by XenoTherapeutics, Inc., Backed by XOMA Royalty Corporation in All-Cash Transaction - The Globe and Mail
ESSA Pharma Shareholders to Receive $1.91 Cash Plus CVR in XenoTherapeutics Acquisition Deal - Stock Titan
14,525 Shares in ESSA Pharma Inc. (NASDAQ:EPIX) Bought by Squarepoint Ops LLC - Defense World
211,204 Shares in ESSA Pharma Inc. (NASDAQ:EPIX) Acquired by Two Sigma Investments LP - Defense World
Jane Street Group LLC Acquires Shares of 45,810 ESSA Pharma Inc. (NASDAQ:EPIX) - Defense World
82,600 Shares in ESSA Pharma Inc. (NASDAQ:EPIX) Purchased by Two Sigma Advisers LP - Defense World
Bank of America Corp DE Buys 812,302 Shares of ESSA Pharma Inc. (NASDAQ:EPIX) - Defense World
BNP Paribas Financial Markets Raises Stock Holdings in ESSA Pharma Inc. (NASDAQ:EPIX) - Defense World
ESSA Pharma Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky for More InformationEPIX - ACCESS Newswire
Cubist Systematic Strategies LLC Buys Shares of 26,287 ESSA Pharma Inc. (NASDAQ:EPIX) - Defense World
ESSA Pharma Inc. Explores Strategic Alternatives After Clinical Trial Termination - TipRanks
ESSA Pharma: Fiscal Q2 Earnings Snapshot - CT Insider
ESSA Pharma Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2025 - marketscreener.com
ESSA Pharma Reports Q2 2025 Financial Results and Strategic Review - TipRanks
ESSA Pharma Reports Financial Results for Fiscal Second Quarter Ended March 31, 2025 | EPIX Stock News - GuruFocus
ESSA Pharma Reports Financial Results for Fiscal Second Quarter Ended March 31, 2025 - Stock Titan
Press Release Distribution & PR Platform - ACCESS Newswire
Essa Pharma Inc Azioni (EPIX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.87%
0.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):